Ella Ekholm
About
In The Last Decade
Ella Ekholm
14 papers receiving 444 citations
Peers
Comparison fields: 5 of 64
- Endocrinology, Diabetes and Metabolism 345
- Surgery 219
- Molecular Biology 208
- Physiology 86
- Pulmonary and Respiratory Medicine 76
Countries citing papers authored by Ella Ekholm
This map shows the geographic impact of Ella Ekholm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ella Ekholm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ella Ekholm more than expected).
Fields of papers citing papers by Ella Ekholm
This network shows the impact of papers produced by Ella Ekholm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ella Ekholm. The network helps show where Ella Ekholm may publish in the future.
Co-authorship network of co-authors of Ella Ekholm
This figure shows the co-authorship network connecting the top 25 collaborators of Ella Ekholm. A scholar is included among the top collaborators of Ella Ekholm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ella Ekholm. Ella Ekholm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 11 | |
| 3 | 8 | |
| 4 | 1 | |
| 5 | 1 | |
| 6 | 8 | |
| 7 | 22 | |
| 8 | A Randomized, Double-Blind, Phase 3 Trial of Dapagliflozin Add-on to Saxagliptin plus Metformin in Type 2 Diabetes | 2 |
| 9 | 125 | |
| 10 | 77 | |
| 11 | 40 | |
| 12 | 52 | |
| 13 | 80 | |
| 14 | 35 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.